0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Spinal Muscular Atrophy Market Insights, Forecast to 2029
Published Date: June 2023
|
Report Code: QYRE-Auto-17E3311
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Spinal Muscular Atrophy Market Insights and Forecast to 2028
BUY CHAPTERS

Global Spinal Muscular Atrophy Market Insights, Forecast to 2029

Code: QYRE-Auto-17E3311
Report
June 2023
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Spinal Muscular Atrophy Market Size

The global Spinal Muscular Atrophy market is projected to grow from US$ 1400 million in 2023 to US$ 2573.5 million by 2029, at a Compound Annual Growth Rate (CAGR) of 10.7% during the forecast period.

Spinal Muscular Atrophy Market

Spinal Muscular Atrophy Market

Market Analysis and Insights: Global Spinal Muscular Atrophy Market
The US & Canada market for Spinal Muscular Atrophy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Spinal Muscular Atrophy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Spinal Muscular Atrophy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Spinal Muscular Atrophy include Lonis Pharmaceuticals, F. Hoffmann-La Roche, AveXis, Novartis, Cytokinetics and Ionis Pharmaceuticals, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Spinal Muscular Atrophy market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Spinal Muscular Atrophy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Spinal Muscular Atrophy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Spinal Muscular Atrophy revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Spinal Muscular Atrophy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Spinal Muscular Atrophy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Lonis Pharmaceuticals, F. Hoffmann-La Roche, AveXis, Novartis, Cytokinetics and Ionis Pharmaceuticals, etc.

Scope of Spinal Muscular Atrophy Market Report

Report Metric Details
Report Name Spinal Muscular Atrophy Market
Accounted market size in 2023 US$ 1400 million
Forecasted market size in 2029 US$ 2573.5 million
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Early Stage Candidates
  • Late Stage Candidates
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonis Pharmaceuticals, F. Hoffmann-La Roche, AveXis, Novartis, Cytokinetics, Ionis Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Spinal Muscular Atrophy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Spinal Muscular Atrophy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by application and by country, revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, revenue for each segment.
  • Chapter 8: China by type and by application revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Spinal Muscular Atrophy revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Early Stage Candidates
1.2.3 Late Stage Candidates
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy Market Perspective (2018-2029)
2.2 Global Spinal Muscular Atrophy Growth Trends by Region
2.2.1 Spinal Muscular Atrophy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Spinal Muscular Atrophy Historic Market Size by Region (2018-2023)
2.2.3 Spinal Muscular Atrophy Forecasted Market Size by Region (2024-2029)
2.3 Spinal Muscular Atrophy Market Dynamics
2.3.1 Spinal Muscular Atrophy Industry Trends
2.3.2 Spinal Muscular Atrophy Market Drivers
2.3.3 Spinal Muscular Atrophy Market Challenges
2.3.4 Spinal Muscular Atrophy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Spinal Muscular Atrophy by Players
3.1.1 Global Spinal Muscular Atrophy Revenue by Players (2018-2023)
3.1.2 Global Spinal Muscular Atrophy Revenue Market Share by Players (2018-2023)
3.2 Global Spinal Muscular Atrophy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Spinal Muscular Atrophy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Spinal Muscular Atrophy Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Revenue in 2022
3.5 Global Key Players of Spinal Muscular Atrophy Head office and Area Served
3.6 Global Key Players of Spinal Muscular Atrophy, Product and Application
3.7 Global Key Players of Spinal Muscular Atrophy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Spinal Muscular Atrophy Breakdown Data by Type
4.1 Global Spinal Muscular Atrophy Historic Market Size by Type (2018-2023)
4.2 Global Spinal Muscular Atrophy Forecasted Market Size by Type (2024-2029)
5 Spinal Muscular Atrophy Breakdown Data by Application
5.1 Global Spinal Muscular Atrophy Historic Market Size by Application (2018-2023)
5.2 Global Spinal Muscular Atrophy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Spinal Muscular Atrophy Market Size (2018-2029)
6.2 North America Spinal Muscular Atrophy Market Size by Type
6.2.1 North America Spinal Muscular Atrophy Market Size by Type (2018-2023)
6.2.2 North America Spinal Muscular Atrophy Market Size by Type (2024-2029)
6.2.3 North America Spinal Muscular Atrophy Market Share by Type (2018-2029)
6.3 North America Spinal Muscular Atrophy Market Size by Application
6.3.1 North America Spinal Muscular Atrophy Market Size by Application (2018-2023)
6.3.2 North America Spinal Muscular Atrophy Market Size by Application (2024-2029)
6.3.3 North America Spinal Muscular Atrophy Market Share by Application (2018-2029)
6.4 North America Spinal Muscular Atrophy Market Size by Country
6.4.1 North America Spinal Muscular Atrophy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Spinal Muscular Atrophy Market Size by Country (2018-2023)
6.4.3 North America Spinal Muscular Atrophy Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Spinal Muscular Atrophy Market Size (2018-2029)
7.2 Europe Spinal Muscular Atrophy Market Size by Type
7.2.1 Europe Spinal Muscular Atrophy Market Size by Type (2018-2023)
7.2.2 Europe Spinal Muscular Atrophy Market Size by Type (2024-2029)
7.2.3 Europe Spinal Muscular Atrophy Market Share by Type (2018-2029)
7.3 Europe Spinal Muscular Atrophy Market Size by Application
7.3.1 Europe Spinal Muscular Atrophy Market Size by Application (2018-2023)
7.3.2 Europe Spinal Muscular Atrophy Market Size by Application (2024-2029)
7.3.3 Europe Spinal Muscular Atrophy Market Share by Application (2018-2029)
7.4 Europe Spinal Muscular Atrophy Market Size by Country
7.4.1 Europe Spinal Muscular Atrophy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Spinal Muscular Atrophy Market Size by Country (2018-2023)
7.4.3 Europe Spinal Muscular Atrophy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Spinal Muscular Atrophy Market Size (2018-2029)
8.2 China Spinal Muscular Atrophy Market Size by Type
8.2.1 China Spinal Muscular Atrophy Market Size by Type (2018-2023)
8.2.2 China Spinal Muscular Atrophy Market Size by Type (2024-2029)
8.2.3 China Spinal Muscular Atrophy Market Share by Type (2018-2029)
8.3 China Spinal Muscular Atrophy Market Size by Application
8.3.1 China Spinal Muscular Atrophy Market Size by Application (2018-2023)
8.3.2 China Spinal Muscular Atrophy Market Size by Application (2024-2029)
8.3.3 China Spinal Muscular Atrophy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Spinal Muscular Atrophy Market Size (2018-2029)
9.2 Asia Spinal Muscular Atrophy Market Size by Type
9.2.1 Asia Spinal Muscular Atrophy Market Size by Type (2018-2023)
9.2.2 Asia Spinal Muscular Atrophy Market Size by Type (2024-2029)
9.2.3 Asia Spinal Muscular Atrophy Market Share by Type (2018-2029)
9.3 Asia Spinal Muscular Atrophy Market Size by Application
9.3.1 Asia Spinal Muscular Atrophy Market Size by Application (2018-2023)
9.3.2 Asia Spinal Muscular Atrophy Market Size by Application (2024-2029)
9.3.3 Asia Spinal Muscular Atrophy Market Share by Application (2018-2029)
9.4 Asia Spinal Muscular Atrophy Market Size by Region
9.4.1 Asia Spinal Muscular Atrophy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Spinal Muscular Atrophy Market Size by Region (2018-2023)
9.4.3 Asia Spinal Muscular Atrophy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Lonis Pharmaceuticals
11.1.1 Lonis Pharmaceuticals Company Details
11.1.2 Lonis Pharmaceuticals Business Overview
11.1.3 Lonis Pharmaceuticals Spinal Muscular Atrophy Introduction
11.1.4 Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2018-2023)
11.1.5 Lonis Pharmaceuticals Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Spinal Muscular Atrophy Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Recent Developments
11.3 AveXis
11.3.1 AveXis Company Details
11.3.2 AveXis Business Overview
11.3.3 AveXis Spinal Muscular Atrophy Introduction
11.3.4 AveXis Revenue in Spinal Muscular Atrophy Business (2018-2023)
11.3.5 AveXis Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Spinal Muscular Atrophy Introduction
11.4.4 Novartis Revenue in Spinal Muscular Atrophy Business (2018-2023)
11.4.5 Novartis Recent Developments
11.5 Cytokinetics
11.5.1 Cytokinetics Company Details
11.5.2 Cytokinetics Business Overview
11.5.3 Cytokinetics Spinal Muscular Atrophy Introduction
11.5.4 Cytokinetics Revenue in Spinal Muscular Atrophy Business (2018-2023)
11.5.5 Cytokinetics Recent Developments
11.6 Ionis Pharmaceuticals
11.6.1 Ionis Pharmaceuticals Company Details
11.6.2 Ionis Pharmaceuticals Business Overview
11.6.3 Ionis Pharmaceuticals Spinal Muscular Atrophy Introduction
11.6.4 Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2018-2023)
11.6.5 Ionis Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Spinal Muscular Atrophy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Early Stage Candidates
    Table 3. Key Players of Late Stage Candidates
    Table 4. Global Spinal Muscular Atrophy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 5. Global Spinal Muscular Atrophy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Spinal Muscular Atrophy Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Spinal Muscular Atrophy Market Share by Region (2018-2023)
    Table 8. Global Spinal Muscular Atrophy Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Spinal Muscular Atrophy Market Share by Region (2024-2029)
    Table 10. Spinal Muscular Atrophy Market Trends
    Table 11. Spinal Muscular Atrophy Market Drivers
    Table 12. Spinal Muscular Atrophy Market Challenges
    Table 13. Spinal Muscular Atrophy Market Restraints
    Table 14. Global Spinal Muscular Atrophy Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Spinal Muscular Atrophy Revenue Share by Players (2018-2023)
    Table 16. Global Top Spinal Muscular Atrophy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy as of 2022)
    Table 17. Global Spinal Muscular Atrophy Industry Ranking 2021 VS 2022 VS 2023
    Table 18. Global 5 Largest Players Market Share by Spinal Muscular Atrophy Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Global Key Players of Spinal Muscular Atrophy, Headquarters and Area Served
    Table 20. Global Key Players of Spinal Muscular Atrophy, Product and Application
    Table 21. Global Key Players of Spinal Muscular Atrophy, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Spinal Muscular Atrophy Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Spinal Muscular Atrophy Revenue Market Share by Type (2018-2023)
    Table 25. Global Spinal Muscular Atrophy Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Spinal Muscular Atrophy Revenue Market Share by Type (2024-2029)
    Table 27. Global Spinal Muscular Atrophy Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Spinal Muscular Atrophy Revenue Share by Application (2018-2023)
    Table 29. Global Spinal Muscular Atrophy Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Spinal Muscular Atrophy Revenue Share by Application (2024-2029)
    Table 31. North America Spinal Muscular Atrophy Market Size by Type (2018-2023) & (US$ Million)
    Table 32. North America Spinal Muscular Atrophy Market Size by Type (2024-2029) & (US$ Million)
    Table 33. North America Spinal Muscular Atrophy Market Size by Application (2018-2023) & (US$ Million)
    Table 34. North America Spinal Muscular Atrophy Market Size by Application (2024-2029) & (US$ Million)
    Table 35. North America Spinal Muscular Atrophy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America Spinal Muscular Atrophy Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America Spinal Muscular Atrophy Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe Spinal Muscular Atrophy Market Size by Type (2018-2023) & (US$ Million)
    Table 39. Europe Spinal Muscular Atrophy Market Size by Type (2024-2029) & (US$ Million)
    Table 40. Europe Spinal Muscular Atrophy Market Size by Application (2018-2023) & (US$ Million)
    Table 41. Europe Spinal Muscular Atrophy Market Size by Application (2024-2029) & (US$ Million)
    Table 42. Europe Spinal Muscular Atrophy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. Europe Spinal Muscular Atrophy Market Size by Country (2018-2023) & (US$ Million)
    Table 44. Europe Spinal Muscular Atrophy Market Size by Country (2024-2029) & (US$ Million)
    Table 45. China Spinal Muscular Atrophy Market Size by Type (2018-2023) & (US$ Million)
    Table 46. China Spinal Muscular Atrophy Market Size by Type (2024-2029) & (US$ Million)
    Table 47. China Spinal Muscular Atrophy Market Size by Application (2018-2023) & (US$ Million)
    Table 48. China Spinal Muscular Atrophy Market Size by Application (2024-2029) & (US$ Million)
    Table 49. Asia Spinal Muscular Atrophy Market Size by Type (2018-2023) & (US$ Million)
    Table 50. Asia Spinal Muscular Atrophy Market Size by Type (2024-2029) & (US$ Million)
    Table 51. Asia Spinal Muscular Atrophy Market Size by Application (2018-2023) & (US$ Million)
    Table 52. Asia Spinal Muscular Atrophy Market Size by Application (2024-2029) & (US$ Million)
    Table 53. Asia Spinal Muscular Atrophy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 54. Asia Spinal Muscular Atrophy Market Size by Region (2018-2023) & (US$ Million)
    Table 55. Asia Spinal Muscular Atrophy Market Size by Region (2024-2029) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Type (2018-2023) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Type (2024-2029) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Application (2018-2023) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Application (2024-2029) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Spinal Muscular Atrophy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 61. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Country (2018-2023) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size by Country (2024-2029) & (US$ Million)
    Table 63. Lonis Pharmaceuticals Company Details
    Table 64. Lonis Pharmaceuticals Business Overview
    Table 65. Lonis Pharmaceuticals Spinal Muscular Atrophy Product
    Table 66. Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
    Table 67. Lonis Pharmaceuticals Recent Developments
    Table 68. F. Hoffmann-La Roche Company Details
    Table 69. F. Hoffmann-La Roche Business Overview
    Table 70. F. Hoffmann-La Roche Spinal Muscular Atrophy Product
    Table 71. F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
    Table 72. F. Hoffmann-La Roche Recent Developments
    Table 73. AveXis Company Details
    Table 74. AveXis Business Overview
    Table 75. AveXis Spinal Muscular Atrophy Product
    Table 76. AveXis Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
    Table 77. AveXis Recent Developments
    Table 78. Novartis Company Details
    Table 79. Novartis Business Overview
    Table 80. Novartis Spinal Muscular Atrophy Product
    Table 81. Novartis Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
    Table 82. Novartis Recent Developments
    Table 83. Cytokinetics Company Details
    Table 84. Cytokinetics Business Overview
    Table 85. Cytokinetics Spinal Muscular Atrophy Product
    Table 86. Cytokinetics Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
    Table 87. Cytokinetics Recent Developments
    Table 88. Ionis Pharmaceuticals Company Details
    Table 89. Ionis Pharmaceuticals Business Overview
    Table 90. Ionis Pharmaceuticals Spinal Muscular Atrophy Product
    Table 91. Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
    Table 92. Ionis Pharmaceuticals Recent Developments
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Spinal Muscular Atrophy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Spinal Muscular Atrophy Market Share by Type: 2022 VS 2029
    Figure 3. Early Stage Candidates Features
    Figure 4. Late Stage Candidates Features
    Figure 5. Global Spinal Muscular Atrophy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 6. Global Spinal Muscular Atrophy Market Share by Application: 2022 VS 2029
    Figure 7. Hospital Case Studies
    Figure 8. Clinic Case Studies
    Figure 9. Others Case Studies
    Figure 10. Spinal Muscular Atrophy Report Years Considered
    Figure 11. Global Spinal Muscular Atrophy Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Spinal Muscular Atrophy Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Spinal Muscular Atrophy Market Share by Region: 2022 VS 2029
    Figure 14. Global Spinal Muscular Atrophy Market Share by Players in 2022
    Figure 15. Global Top Spinal Muscular Atrophy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy Revenue in 2022
    Figure 17. North America Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Spinal Muscular Atrophy Market Share by Type (2018-2029)
    Figure 19. North America Spinal Muscular Atrophy Market Share by Application (2018-2029)
    Figure 20. North America Spinal Muscular Atrophy Market Share by Country (2018-2029)
    Figure 21. United States Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Canada Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Spinal Muscular Atrophy Market Size YoY (2018-2029) & (US$ Million)
    Figure 24. Europe Spinal Muscular Atrophy Market Share by Type (2018-2029)
    Figure 25. Europe Spinal Muscular Atrophy Market Share by Application (2018-2029)
    Figure 26. Europe Spinal Muscular Atrophy Market Share by Country (2018-2029)
    Figure 27. Germany Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. France Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. U.K. Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Italy Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Russia Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Nordic Countries Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. China Spinal Muscular Atrophy Market Size YoY (2018-2029) & (US$ Million)
    Figure 34. China Spinal Muscular Atrophy Market Share by Type (2018-2029)
    Figure 35. China Spinal Muscular Atrophy Market Share by Application (2018-2029)
    Figure 36. Asia Spinal Muscular Atrophy Market Size YoY (2018-2029) & (US$ Million)
    Figure 37. Asia Spinal Muscular Atrophy Market Share by Type (2018-2029)
    Figure 38. Asia Spinal Muscular Atrophy Market Share by Application (2018-2029)
    Figure 39. Asia Spinal Muscular Atrophy Market Share by Region (2018-2029)
    Figure 40. Japan Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. South Korea Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. China Taiwan Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Southeast Asia Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. India Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Australia Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Size YoY (2018-2029) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Share by Type (2018-2029)
    Figure 48. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Share by Application (2018-2029)
    Figure 49. Middle East, Africa, and Latin America Spinal Muscular Atrophy Market Share by Country (2018-2029)
    Figure 50. Brazil Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 51. Mexico Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 52. Turkey Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 53. Saudi Arabia Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Israel Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. GCC Countries Spinal Muscular Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. Lonis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
    Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
    Figure 58. AveXis Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
    Figure 59. Novartis Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
    Figure 60. Cytokinetics Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
    Figure 61. Ionis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS